Latest news

Thursday 16 March 2017
Six teams have been awarded over half a million pounds of funding for proof-of-concept studies.
Press Release
Wednesday 08 March 2017
Work investigating the welfare of laboratory rats is the winner of the 2016 3Rs prize, sponsored by GlaxoSmithKline.
Tuesday 07 March 2017
Are you considering outsourcing your animal research? Our new resource provides advice and guidance.
Staff Blog
Thursday 02 March 2017
We are launching a number of exciting initiatives in 2017 focusing on the welfare of rats and mice.
Thursday 23 February 2017
A recent review has summarised current and future opportunities to apply the 3Rs in the safety assessment of pharmaceuticals.
Tuesday 21 February 2017
Scientists at the NC3Rs, AstraZeneca and University of Plymouth have conducted the largest survey to-date on the use and care of zebrafish in research. The results are published this week in Journal of Fish Biology and cover anaesthesia and euthanasia methods, housing and husbandry, breeding and production.
Wednesday 15 February 2017
EU-based academics and SMEs whose technology is featured on the NC3Rs CRACK IT Solutions partnering platform will now be able to apply for funding of up to £50k to support collaborations that are identified through the platform.
Friday 03 February 2017
A recent cross-sector review has highlighted several key approaches available for ecotoxicologists and risk assessors to evaluate potentially hazardous chemicals, while minimising the use of vertebrates.
Thursday 26 January 2017
We are pleased to announce seven new fellowships, a commitment of nearly £1.2 million to support talented early career scientists in the discovery and development of new technologies and approaches to replace, reduce and refine the use of animals in scientific research. We provide two types of fellowship...
Tuesday 24 January 2017
An innovative project has been awarded funding through the NC3Rs CRACK IT Solutions partnering programme which supports collaborations to develop and validate new technologies with commercial and 3Rs potential.